Cite

    Huang, X. et al. (2014). An allopurinol‐controlled, multicenter, randomized, double‐blind, parallel between‐group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia. International journal of rheumatic diseases. pp. 679-686. [Online].